Trials / Unknown
UnknownNCT03278691
Ketorolac on Posterior Thoracolumbar Spinal Fusions
The Effect of Ketorolac on Posterior Thoracolumbar Spinal Fusions: a Prospective Randomized Controlled Trial
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 600 (estimated)
- Sponsor
- Henry Ford Health System · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
To determine is low-dose ketorolac use in the early post-operative period (within 48 hours) provides adequate analgesia without long term adverse effect on spinal fusion rates when compared to post-operative analgesia without the use of NSAIDs.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Saline | 1 ml saline IV Q6H |
| DRUG | Ketorolac | 15 mg (15 mg/ml) IV Q6H |
Timeline
- Start date
- 2017-10-03
- Primary completion
- 2023-12-31
- Completion
- 2025-12-31
- First posted
- 2017-09-12
- Last updated
- 2023-04-20
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03278691. Inclusion in this directory is not an endorsement.